Clinical Trial Update: Fludarabine/Rituximab Combined With Escalating Doses of Lenalidomide in Untreated CLL [Phase 1, Phase 2]

View source ↗

Summary

This update reports results from a Phase 1/2 trial evaluating escalating doses of lenalidomide added to fludarabine and rituximab in previously untreated chroni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Fludarabine (Fludarabine)
• Lenalidomide (lenalidomide)
• Rituximab (rituximab)

Snippet

Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie | Conditions: CLL, Chronic Lymphocytic Leukemia | Phase 1, Phase 2 | Status: COMPLETED